State’s exit from GM site ownership signals new economic development approach
“The governor has been very clear: We’re just not in the land development business, and it’s not a core competency,” Commerce Secretary David Adams told IBJ.
Elanco
State sells former GM stamping plant site to Elanco for $27M
Indiana Gov. Mike Braun said the agreement “enables Elanco and its partners, including Purdue University, to accelerate the creation of an innovation district in downtown Indianapolis.”
Elanco CEO says new products helping to turn the corner on growth
Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co.
Elanco spearheads Nutrition Secure Indianapolis initiative to provide food aid to west-side families
As the Greenfield-based animal health company prepares to move into its new neighborhood, it’s working with community partners to help ensure some of its new neighbors have adequate food access.
UPDATE: Elanco shares jump 16% as company raises full-year guidance
The company, which makes vaccines, antibiotics and other animal-health products, said it now expects full-year revenue of between $4.57 billion and $4.62 billion.
Elanco ramps up debt repayment, sells future royalties of flea and tick medicine for human use
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
Pet perks: More employers offering pet insurance, letting pups come to the office
The rise of pet insurance and pet-friendly workplaces comes amid wider societal changes with health benefits experts citing people waiting longer to have children and increasingly treating pets as part of the family.
Elanco buys manufacturing facility in England for $25M
Greenfield-based Elanco said the facility has played a vital role in producing a number of product lines for the firm, representing $160 million to $180 million in annual farm animal revenue.
White River State Park reveals plans for $65M expansion on stamping plant site
The park will expand into 15 acres between the White River and Elanco Animal Health’s new headquarters and will include an event pavilion to be developed inside the remnants of a former crane bay that had been part of the original stamping plant.
Sculpture at Elanco campus expected to make a splash for public art
“Water in Dripping, River,” a stainless steel sculpture by Chinese artist Zheng Lu, is an $846,000 project that will set a new standard for works financed through the Public Art for Neighborhoods ordinance.
Elanco gets FDA approval for third new product this year
The product, called Credelio Quattro, is designed to protect against fleas, ticks, heartworms, roundworms, hookworms and three different species of tapeworms.
Elanco’s dermatology treatment for itchy dogs gets FDA approval
Zenrelia is one of several drugs Elanco has in its pipeline that it predicts could reach blockbuster status, which in animal health means more than $100 million in annual sales.
IEDC still looking for buyers for portion of GM stamping plant property
Economic development leaders want the 45 acres to be developed as the OneHealth Innovation District—a partnership between Elanco Animal Health, Purdue University and the Indiana Economic Development Corp.
Three Hancock County organizations partner to acquire Elanco’s Greenfield HQ property
Pride Investment Partners, Hancock Health and energy cooperative NineStar Connect collaborated on the purchase of the 20.4-acre site through a joint venture called HealthStar Partners.
OneHealth designation could drive innovation in Elanco/Purdue space
State and corporate leaders believe a tech park taking shape on the western edge of downtown could be a launchpad for health sciences innovation and commercialization as part of the state’s ambitious economic development portfolio.
Elanco completes $1.3B sale of aqua business, allowing it to reduce debt load
The company had debt of $5.7 billion as of March 31 and has been under pressure from Wall Street to reduce it.
Elanco to launch product that reduces dairy cattle methane emissions
Elanco has called Bovaer a potential blockbuster, meaning it could ring up annual sales of at least $100 million.
Purdue, Elanco to develop shared-use facility at new innovation district in Indy
Elanco also announced a commitment to purchase an additional 12 acres to the north of its planned headquarters for future expansion and the development of the Epicenter for Animal Health.
Elanco reaches agreement with activist investor, avoiding messy proxy fight
The Greenfield-based maker of animal vaccines, antibiotics and other health products said that as part of the agreement with Ancora Holding Inc., it will appoint two new independent directors supported by the investment firm to its board.
Elanco digs in for fight with activist investor
Ancora Holdings Inc. is pushing for a shakeup in leadership at he Greenfield-based animal health company, which it accuses of delivering poor margins, sluggish product commercialization, negative shareholder returns and poor governance policies.